Extracellular amyloid formation and associated pathology in neural grafts

Nature Neuroscience

Volumn 6, Issue 4, 2003, Pages 370-377

  Meyer Luehmann, Melanie ^a   Stalder, Martina ^a   Herzig, Martin C ^a   Kaeser, Stephan A ^a   Kohler, Esther ^a   Pfeifer, Michelle ^a   Boncristiano, Sonia ^a   Mathews, Paul M ^b   Mercken, Marc ^c   Abramowski, Dorothee ^d   Staufenbiel, Matthias ^d   Jucker, Mathias ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION; DISEASE ASSOCIATION; EXTRACELLULAR SPACE; HIPPOCAMPUS; MOUSE; NEOCORTEX; NERVE CELL; NERVE DEGENERATION; NERVE GRAFT; NEURITE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROCESSING; SENILE PLAQUE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN TISSUE TRANSPLANTATION; DIFFUSION; DISEASE MODELS, ANIMAL; EXTRACELLULAR SPACE; GLIOSIS; GRAFT SURVIVAL; HIPPOCAMPUS; MICE; MICE, TRANSGENIC; NEURONS; PROTEIN TRANSPORT; REACTION TIME; SENILE PLAQUES; SOLUBILITY; UP-REGULATION;

EID: 0037381108     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1022     Document Type: Article

References (50)

1. Hardy, J. & Selkoe, D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356 (2002).
2. Selkoe, D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81, 741-766 (2001).
3. Geula, C. et al. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat. Med. 4, 827-831 (1998).
4. Kane, M.D. et al. Evidence for seeding of beta-amyloid by intracerebral infusion of Alzheimer brain extracts in beta-amyloid precursor proteintransgenic mice. J. Neurosci. 20, 3606-3611 (2000).
5. Martin, L.J., Pardo, C.A., Cork, L.C. & Price, D.L. Synaptic pathology and glial responses to neuronal injury precede the formation ofsenile plaques and amyloid deposits in the aging cerebral cortex. Am. J. Pathol. 145, 1358-1381 (1994).
6. Hartmann, T. et al. Distinct sites of intracellular production for Alzheimer's disease Abeta40/42 amyloid peptides. Nat. Med. 3, 1016-1020 (1997).
7. Gouras, G.K. et al. Intraneuronal Abeta42 accumulation in human brain. Am. J. Pathol. 156, 15-20 (2000).
8. Walsh, D.M., Tseng, B.P., Rydel, R.E., Podlisny, M.B. & Selkoe, D.J. The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry 39, 10831-10839 (2000).
9. Bayer, T.A. et al. Key factors in Alzheimer's disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport. Brain Pathol. 11, 1-11 (2001).
10. Wirths, O. et al. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 doubletransgenic mice. Neurosci. Lett. 306, 116-120 (2001).
11. D'Andrea, M.R., Nagele, R.G., Wang, H.Y., Peterson, P.A. & Lee, D.H. Evidence that neurons accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38, 120-134 (2001).
12. Brandner, S. et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339-343 (1996).
13. Richards, S.J. et al. Transplants of mouse trisomy 16 hippocampus provide a model of Alzheimer's disease neuropathology. Embo J. 10, 297-303 (1991).
14. Holtzman, D.M. et al. Mouse model of neurodegeneration: atrophy of basal forebrain cholinergic neurons in trisomy 16 transplants. Proc. Natl. Acad. Sci. USA 89, 1383-1387 (1992).
15. Mantione, J.R. et al. Human neurons that constitutively secrete Abeta do not induce Alzheimer's disease pathology following transplantation and longterm survival in the rodent brain. Brain Res. 671, 333-337 (1995).
16. Bayer, T.A., Fossgreen, A., Czech, C., Beyreuther, K. & Wiestler, O.D. Plaque formation in brain transplants exposed to human beta-amyloid precursor protein 695. Acta Neuropathol. (Berl.) 92, 130-137 (1996).
17. Hsiao, K. et al. Correlative memory deficits, Abeta elevation and amyloid plaques in transgenic mice. Science 274, 99-102 (1996).
18. Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373, 523-527 (1995).
19. Sturchler-Pierrat, C. et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA 94, 13287-13292 (1997).
20. Brandner, S. et al. Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system. Proc. Natl. Acad. Sci. USA 93, 13148-13151 (1996).
21. Schenk, D. et al. Immunization with amyloid-beta attenuates Alzheimer disease-like pathology in the PDAPP mouse. Nature 400, 173-177 (1999).
22. Pfeifer, M. et al. Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science 298, 1379 (2002).
23. Calhoun, M.E. et al. Neuron loss in APP transgenic mice. Nature 395, 755-756 (1998).
24. Qiu, W.Q. et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J. Biol. Chem. 273, 32730-32738 (1998).
25. Iwata, N. et al. Identification of the major AbetaI-42- degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat. Med. 6, 143-150 (2000).
26. Clinton, R.J. Jr. & Ebner, F.F. Time course of neocortical graft innervation by AChE-positive fibers. J. Comp. Neurol. 277, 557-577 (1988).
27. Lazarov, O., Lee, M., Peterson, D.A. & Sisodia, S.S. Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J. Neurosci. 22, 9785-9793 (2002).
28. Wirths, O. et al. Intraneuronal APP/A beta trafficking and plaque formation in beta-amyloid precursor protein and presenilin-1 transgenic mice. Brain Pathol. 12, 275-286 (2002).
29. Stalder, M. et al. Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am. J. Pathol. 154, 1673-1684 (1999).
30. Phinney, A.L. et al. Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J. Neurosci. 19, 8552-8559 (1999).
31. Boncristiano, S. et al. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis. J. Neurosci. 22, 3234-3243 (2002).
32. Bondolfi, L. et al. Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice. J. Neurosci. 22, 515-522 (2002).
33. Weller, R.O. Pathology of cerebrospinal fluid and interstitial fiuid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis. J. Neuropathol. Exp. Neurol. 57, 885-894 (1998).
34. Shibata, M. et al. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106, 1489-1499 (2000).
35. DeMattos, R.B., Bales, K.R., Cummins, D.J., Paul, S.M. & Holtzman, D.M. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295, 2264-2267 (2002).
36. Calhoun, M.E. et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc. Natl. Acad. Sci. USA 96, 14088-14093 (1999).
37. Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science 298, 789-791 (2002).
38. Bi, X., Gall, C.M., Zhou, J. & Lynch, G. Uptake and pathogenic effects of amyloid beta peptide 1-42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists. Neuroscience 112, 827-840 (2002).
39. Nagele, R.G., D'Andrea, M.R., Anderson, W.J. & Wang, H.Y. Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110, 199-211 (2002).
40. Gates, M.A., Laywell, E.D., Fillmore, H. & Steindler, D.A. Astrocytes and extracellular matrix following intracerebral transplantation of embryonic ventral mesencephalon or lateral ganglionic eminence. Neuroscience 74, 579-597 (1996).
41. Sykova, E., Roitbak, T., Mazel, T., Simonova, Z. & Harvey, A.R. Astrocytes, oligodendroglia, extracellular space volume and geometry in rat fetal brain grafts. Neuroscience 91, 783-798 (1999).
42. Snow, A.D. et al. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron 12, 219-234 (1994).
43. Wild-Bode, C. et al. Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42. J. Biol. Chem. 272, 16085-16088 (1997).
44. Urbanc, B. et al. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 99, 13990-13995 (2002).
45. Wong, T.P., Debeir, T, Duff, K. & Cuello, A.C. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes. J. Neurosci. 19, 2706-2716 (1999).
46. Frautschy, S.A. et al. Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 152, 307-317 (1998).
47. Mathews, P.M. et al. Calpain activity regulates the cell surface distribution of amyloid precursor protein. Inhibition of calpains enhances endosomal generation of beta-cleaved C-terminal APP fragments. J. Biol. Chem. 277, 36415-36424 (2002).
48. Ohsawa, K., Imai, Y., Kanazawa, H., Sasaki, Y. & Kohsaka, S. Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J. Cell. Sci. 113, 3073-3084 (2000).
49. Palkovits, M. Punch sampling biopsy technique. Methods Enzymol. 103, 368-376 (1983).
50. Wihfang, J. et al. Improved electrophoretic separation and immunoblotting of beta-amyloid (A beta) peptides 1-40, 1-42 and 1-43. Electrophoresis 18, 527-532 (1997).